AURORA, ON--(Marketwired - April 15, 2016) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company"), a biopharmaceutical company developing innovative drug candidates for the ...
Toronto, Ontario (22 August 2025)– TheNewswire -Helix BioPharma Corp. (HBP:CA) (TSX: “HBP”, OTC: “HBPCF”, FRANKFURT: “HBP0”)(“Helix”or the“Company ...
(MENAFN- GlobeNewsWire - Nasdaq) itemprop="articleBody">RICHMOND HILL, Ontario, April 29, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: 'HBP') ('Helix' or the ...
Helix's actual results could differ materially from these forward-looking statements and information as a result of numerous risk factors, including without limitation, the risk that that proceeds of ...